Six-time Institutional Investor magazine #1 ranked pharmaceutical analyst with a career record of integrity, thought leadership, strategic vision, and business insight leading to significant business growth and shareholder value. Recognized as a leading expert in the healthcare and pharmaceutical industries, with an extensive network of top industry leaders at public, private, and Fortune 100 companies. Experience on both the buy-side at a leading hedge fund and the sell-side. Former contributor to Forbes.A client-focused leader who is a trusted advisor and partner to clients, investors, and boards of directors; cultivates and maintains credible, long-term relationships. Provides differentiated, relevant industry views, detailed financial and valuation models, deep market insight, and highly respected investment opinions. Sought out for industry expertise; frequent guest on CNBC, Bloomberg, CBS Evening News, NBS Evening News, and ABC Evening News; and featured speaker at industry conferences, seminars, and other symposia. Widely quoted and profiled by leading publications such as The Wall Street Journal, The New York Times, and The Financial Times, among others. Called the Last Honest Analyst by Smart Money magazine.